These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8527261)

  • 1. Treatment of Parkinson's disease in a patient with acute intermittent porphyria.
    Gorchein A
    Br J Clin Pharmacol; 1995 Jul; 40(1):105-6. PubMed ID: 8527261
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug management of Parkinson's disease.
    Kishore A; Snow BJ
    Can Fam Physician; 1996 May; 42():946-52. PubMed ID: 8688697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Benefits of a new galenic form of levodopa and benserazide in the treatment of patients with Parkinson disease].
    Dessibourg CA; Gachoud JP
    Praxis (Bern 1994); 1995 Oct; 84(43):1235-8. PubMed ID: 7481341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Benefits of the combination of mucuna, green tea and levodopa/benserazide in Parkinson's disease].
    Gonzalez-Maldonado R; Gonzalez-Redondo R; Di Caudo C
    Rev Neurol; 2016 Jun; 62(11):524-6. PubMed ID: 27222087
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug therapy of Parkinson's disease].
    Zhou XD
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):193-6. PubMed ID: 4075905
    [No Abstract]   [Full Text] [Related]  

  • 6. Parkinsonism complicating acute organophosphate insecticide poisoning.
    Hashim HZ; Wan Musa WR; Ngiu CS; Wan Yahya WN; Tan HJ; Ibrahim N
    Ann Acad Med Singap; 2011 Mar; 40(3):150-1. PubMed ID: 21603737
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperthyroidism "masked" the levodopa response in newly diagnosed Parkinson's disease patients.
    Prakash KM; Kek PC
    Parkinsonism Relat Disord; 2010 Dec; 16(10):691-2. PubMed ID: 20729126
    [No Abstract]   [Full Text] [Related]  

  • 8. [Disturbance of micturition in Parkinson's disease].
    Sakakibara R; Uchiyama T; Yoshiyama M; Hattori T
    No To Shinkei; 2001 Nov; 53(11):1009-14. PubMed ID: 11761908
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of Parkinson's disease. Practical criteria of treatment].
    Casacchia M; Carolei A; Zamponi A; Agnoli A; Fazio C
    Recenti Prog Med; 1976 May; 60(5):567-84. PubMed ID: 14360
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficiency of new forms of madopar in Parkinson's disease].
    Vendrova MI; Sadekov RA; Golubev VL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):46-8. PubMed ID: 11195538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in Parkinson's disease therapy improved punding but not feeling of presence.
    Aquino CC; Celso de Castro P; Doná F; Medeiros L; Silva SM; Borges V; Ferraz HB
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):E43-4. PubMed ID: 24026740
    [No Abstract]   [Full Text] [Related]  

  • 12. Zoophilia and Parkinson's disease.
    Almeida KJ; de Oliveira Filho MC; Lopes Nery PC; Guimarães Silva JS; Campos Sousa RN
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1167-8. PubMed ID: 23973014
    [No Abstract]   [Full Text] [Related]  

  • 13. 3-O-Methyldopa in Parkinson's disease.
    Muenter MD; Sharpless NS; Tyce GM
    Adv Neurol; 1974; 5():309-15. PubMed ID: 4440579
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-off.
    Kuoppamäki M; Leinonen M; Poewe W
    J Neural Transm (Vienna); 2015 Dec; 122(12):1709-14. PubMed ID: 26347184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration-effect relationship of levodopa-benserazide dispersible formulation versus standard form in the treatment of complicated motor response fluctuations in Parkinson's disease.
    Contin M; Riva R; Martinelli P; Cortelli P; Albani F; Baruzzi A
    Clin Neuropharmacol; 1999; 22(6):351-5. PubMed ID: 10626097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy in Parkinson's disease].
    van Hilten JJ; Roos RA
    Ned Tijdschr Geneeskd; 1999 Jan; 143(5):234-40. PubMed ID: 10086151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone and prolactin stimulation by Madopar in Parkinson's disease.
    Martinez-Campos A; Giovannini P; Parati E; Novelli A; Caraceni T; Müller EE
    J Neurol Neurosurg Psychiatry; 1981 Dec; 44(12):1116-23. PubMed ID: 7334406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute renal failure after massive voluntary intoxication with levodopa (MODOPAR)].
    Barcat D; Constans J; Delpeu K; Banwarth B; Conri C
    Therapie; 1998; 53(6):598-600. PubMed ID: 10070242
    [No Abstract]   [Full Text] [Related]  

  • 19. [Parkinson's disease and pregnancy: case report and literature review].
    Routiot T; Lurel S; Denis E; Barbarino-Monnier P
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):454-7. PubMed ID: 11011274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levodopa dependence and abuse in Parkinson's disease.
    Spigset O; von Schéele C
    Pharmacotherapy; 1997; 17(5):1027-30. PubMed ID: 9324193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.